Vital Therapies raises another $46 million in a public stock offering as it works on its liver regeneration technology.
Vital Therapies (NSDQ:VTL) raised $46 million in a public offering of stock for its technique for the regeneration of liver tissue.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1mSWHcG
Cap comentari:
Publica un comentari a l'entrada